CN1086299C - Chinese-medicinal oral nerve growth liquid - Google Patents

Chinese-medicinal oral nerve growth liquid Download PDF

Info

Publication number
CN1086299C
CN1086299C CN99120671A CN99120671A CN1086299C CN 1086299 C CN1086299 C CN 1086299C CN 99120671 A CN99120671 A CN 99120671A CN 99120671 A CN99120671 A CN 99120671A CN 1086299 C CN1086299 C CN 1086299C
Authority
CN
China
Prior art keywords
radix
gross weight
ingredients
angelicae sinensis
atractylodis macrocephalae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN99120671A
Other languages
Chinese (zh)
Other versions
CN1263768A (en
Inventor
顾晓松
孟凡迅
张沛云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NANTONG MEDICAL COLLEGE
Original Assignee
NANTONG MEDICAL COLLEGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NANTONG MEDICAL COLLEGE filed Critical NANTONG MEDICAL COLLEGE
Priority to CN99120671A priority Critical patent/CN1086299C/en
Publication of CN1263768A publication Critical patent/CN1263768A/en
Application granted granted Critical
Publication of CN1086299C publication Critical patent/CN1086299C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to nerve growth-promoting medium oral liquid which is a traditional Chinese medicine mixture, which comprises the ingredients accounting for the gross weight: 20 to 30% of membranous milkvetch root, 20 to 25% of codonopsis pilosula, 15 to 20% of raw largehead atractylodesrhizome, 9 to 12% of tuber fleeceflower root, 15 to 20% of sweet wolfberry fruit and 11 to 15% of angelica. The process comprises the following steps: respectively finishing the ingredients, removing impurities of the ingredients, drying the ingredients, pulverizing the ingredients by a pulverizer, and sieving the ingredients; mixing the membranous milkvetch root, the codonopsis pilosula, the tuber fleeceflower root and the sweet wolfberry fruit, soaking the membranous milkvetch root, the codonopsis pilosula, the tuber fleeceflower root and the sweet wolfberry fruit with water, and steaming, boiling and filtering the membranous milkvetch root, the codonopsis pilosula, the tuber fleeceflower root and the sweet wolfberry fruit for slag removal and concentration; extracting the largehead atractylodesrhizome and the angelica with ethanol, mixing and concentrating the largehead atractylodesrhizome and the angelica, and packing the mixture. The nerve growth-promoting medium oral liquid is suitable for diseases, such as periphery nerve damage, neuron degeneration, etc. The present invention has the advantages of low toxicity of the pure traditional Chinese medicine preparation, exact effective ingredients, definite curative effect, standard clinical quantification, and large-scale development and popularization.

Description

Chinese-medicinal oral nerve growth liquid
A kind of Chinese medicine oral liquid for the treatment of nerve injury, neuron degeneration illness and preparation method thereof
What the present invention relates to is a kind of herb mixture nerve growth decoction oral liquid for the treatment of illness such as nerve injury, neuron degeneration and preparation method thereof.
Adopt illness such as Chinese herbal treatment nerve injury, though long history is arranged, but because of prescription composition complexity, kind come out one after another, efficacy determination differs, be difficult to scale development and apply, there is a kind of medicine for the treatment of illness such as nerve injury to claim nerve growth factor abroad, belongs to Western medicine, cost an arm and a leg, use inconvenience, curative effect is also unsatisfactory.
The objective of the invention is to the defective at above-mentioned existence, propose a kind of herb mixture-nerve growth decoction, it can effectively treat illness such as nerve injury, neuron degeneration.
Technical solution of the present invention: its proportioning components: the Radix Astragali accounts for the 20-30% of gross weight, 20-25%, the 15-20% that Rhizoma Atractylodis Macrocephalae accounts for gross weight, 9-12%, the 15-20% that Fructus Lycii accounts for gross weight, the 11-15% that Radix Angelicae Sinensis accounts for gross weight that Radix Polygoni Multiflori accounts for gross weight that Radix Codonopsis accounts for gross weight.
Its composition also can increase Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, and they respectively account for the Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, 8-12%, the 5-10% of Radix Angelicae Sinensis gross weight, 5-10%.Increase Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati are to adapt to better people's taste.
The production craft step branch (1) of herb mixture nerve growth decoction oral liquid is if need promptly get above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, Radix Angelicae Sinensis, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati with Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, put, reject impurity respectively in order, and dried, make its water content reach 5-6%; (2) each composition is weighed to scale; (3) pulverize with pulverizer, 60 orders sieve; (4) if need be with Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, the 3-5 water logging doubly that adds its gross weight after also only the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, Fructus Lycii, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi being mixed was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting makes its boiling then, constant temperature 60 minutes, carry out the screen plate filter and remove residue again, concentrate, every milliliter reaches 0.6 gram left and right sides crude drug; (5) with the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Rhizoma Polygonati alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram left and right sides crude drug; (7) packing.
Advantage of the present invention:
This mixture belongs to pure Chinese medicinal preparation, it be in tradition on the basis of proved recipe, utilization modern biology technology is carried out the effect experiment of cellular level to its component, filter out and be rich in the active ingredient that promotes nerve growth, be combined into a kind of novel oral mixture according to Chinese medical theory, take and the result of preliminary clinic trial shows through the SD of sciatic nerve injury rat, this mixture has tangible promotion injured nerve repairing growth, promote the effect of functional rehabilitation, measure through toxicity test, this mixture toxicity is humble, any side effect do not occur, the clinical scope of application: refreshing on every side damage, illness such as neuron degeneration.Its active ingredient is definite, curative effect is clear and definite, clinical quantitative criteria, can scale development and apply.
Embodiment 1
Get 4 kilograms of the Radixs Astragali, 3 kilograms of Radix Codonopsis, 2.5 kilograms of Rhizoma Atractylodis Macrocephalae, 1.9 kilograms of Radix Polygoni Multiflori, 2.5 kilograms of Fructus Lycii, 2.1 kilograms of Radix Angelicae Sinensis
Production craft step branch (1) is got above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, Radix Angelicae Sinensis, puts, rejects impurity respectively in order, and dried, makes its water content reach 5%; (2) each composition is weighed to scale; Get 3 kilograms of the Radixs Astragali, 2 kilograms of Radix Codonopsis, 1.5 kilograms of Rhizoma Atractylodis Macrocephalae, 0.9 kilogram of Radix Polygoni Multiflori, 1.5 kilograms of Fructus Lycii, 1.1 kilograms of Radix Angelicae Sinensis; (3) pulverize with pulverizer, 60 orders sieve; (4) only soaked 24 hours adding 30 kg of water after the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, the Fructus Lycii mixing, carry out under the normal temperature condition, after steaming and decocting made its boiling then, constant temperature 60 minutes carried out the screen plate filter and remove residue again, concentrated, and every milliliter reaches 0.6 gram crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram crude drug; (7) packing.
Embodiment 2
Get 3 kilograms of the Radixs Astragali, 3.3 kilograms of Radix Codonopsis, 2.7 kilograms of Rhizoma Atractylodis Macrocephalae, 2 kilograms of Radix Polygoni Multiflori, 2.7 kilograms of Fructus Lycii, 2.3 kilograms of Radix Angelicae Sinensis.
Increase by 1.9 kilograms of Fructus Jujubaes, 2.0 kilograms of Radix Et Caulis Acanthopanacis Senticosis, 2.0 kilograms of Rhizoma Polygonatis,
Production craft step branch (1) is got above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, Radix Angelicae Sinensis, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, puts, rejects impurity respectively in order, and dried, makes its water content reach 6%; (2) get 2 kilograms of the Radixs Astragali, 2.3 kilograms of Radix Codonopsis, 1.7 kilograms of Rhizoma Atractylodis Macrocephalae, 1 kilogram of Radix Polygoni Multiflori, 1.7 kilograms of Fructus Lycii, 1.3 kilograms of Radix Angelicae Sinensis.Increase by 0.9 kilogram of Fructus Jujubae, 1.0 kilograms of Radix Et Caulis Acanthopanacis Senticosis, 1.0 kilograms of Rhizoma Polygonatis, (3) each composition is pulverized with pulverizer, and 60 orders sieve; (3) water logging that adds 64.5 kilograms after the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, Fructus Lycii, Fructus Jujubae, the Radix Et Caulis Acanthopanacis Senticosi mixing was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting makes its boiling then, constant temperature 60 minutes, carry out the screen plate filter and remove residue again, concentrate, every milliliter reaches 0.6 gram left and right sides crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Rhizoma Polygonati alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram left and right sides crude drug; (7) packing

Claims (4)

1, a kind of Chinese medicine oral liquid for the treatment of nerve injury, neuron degeneration illness.It is characterized in that: it is mainly made by following raw materials according: the Radix Astragali accounts for the 20-30% of gross weight, 20-25%, the 15-20% that Rhizoma Atractylodis Macrocephalae accounts for gross weight, 9-12%, the 15-20% that Fructus Lycii accounts for gross weight, the 11-15% that Radix Angelicae Sinensis accounts for gross weight that Radix Polygoni Multiflori accounts for gross weight that Radix Codonopsis accounts for gross weight.
2, Chinese medicine oral liquid according to claim 1 is characterized in that its raw material also has Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, and they respectively account for the Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, 8-12%, the 5-10% of Radix Angelicae Sinensis gross weight, 5-10%.
3, the preparation method of Chinese medicine oral liquid according to claim 1, the processing step branch (1) that it is characterized in that it is got above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, Radix Angelicae Sinensis, put, reject impurity respectively in order, and dried, make its water content reach 5-6%; (2) each composition is weighed to scale; (3) pulverize with pulverizer, 60 orders sieve; (4) the 3-5 water logging doubly that adds its gross weight after the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, the Fructus Lycii mixing was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting made its boiling then, constant temperature 60 minutes carried out the screen plate filter and remove residue again, concentrated, and every milliliter reaches 0.6 and restrains crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram crude drug; (7) packing.
4, the preparation method of Chinese medicine oral liquid according to claim 2, the processing step branch (1) that it is characterized in that it is got above-mentioned each composition Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Radix Polygoni Multiflori, Fructus Lycii, Radix Angelicae Sinensis, Fructus Jujubae, Radix Et Caulis Acanthopanacis Senticosi, Rhizoma Polygonati, put, reject impurity respectively in order, and dried, make its water content reach 5-6%; (2) each composition is weighed to scale; (3) pulverize with pulverizer, 60 orders sieve; (4) the 3-5 water logging doubly that adds its gross weight after the Radix Astragali, Radix Codonopsis, Radix Polygoni Multiflori, Fructus Lycii, Fructus Jujubae, the Radix Et Caulis Acanthopanacis Senticosi mixing was steeped 24 hours, carry out under the normal temperature condition, after steaming and decocting makes its boiling then, constant temperature 60 minutes, carry out the screen plate filter and remove residue again, concentrate, every milliliter reaches 0.6 gram crude drug; (5) with Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Rhizoma Polygonati alcohol extraction; (6) (4) are mixed the back reconcentration with (5), every milliliter reaches 1 gram crude drug.
CN99120671A 1999-12-29 1999-12-29 Chinese-medicinal oral nerve growth liquid Expired - Lifetime CN1086299C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99120671A CN1086299C (en) 1999-12-29 1999-12-29 Chinese-medicinal oral nerve growth liquid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99120671A CN1086299C (en) 1999-12-29 1999-12-29 Chinese-medicinal oral nerve growth liquid

Publications (2)

Publication Number Publication Date
CN1263768A CN1263768A (en) 2000-08-23
CN1086299C true CN1086299C (en) 2002-06-19

Family

ID=5281635

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99120671A Expired - Lifetime CN1086299C (en) 1999-12-29 1999-12-29 Chinese-medicinal oral nerve growth liquid

Country Status (1)

Country Link
CN (1) CN1086299C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105596978A (en) * 2015-12-23 2016-05-25 薛学明 Drug for treating nerve injury and preparation method thereof
CN111759915A (en) * 2020-07-20 2020-10-13 南通大学 Nerve regeneration compound preparation and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1113808A (en) * 1994-06-14 1995-12-27 鲁守龙 Medicine for curing nervous system injury and angionosis
CN1156608A (en) * 1996-12-10 1997-08-13 艾津华 Chinese medicine for treating nerve system disease and producing process thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1113808A (en) * 1994-06-14 1995-12-27 鲁守龙 Medicine for curing nervous system injury and angionosis
CN1156608A (en) * 1996-12-10 1997-08-13 艾津华 Chinese medicine for treating nerve system disease and producing process thereof

Also Published As

Publication number Publication date
CN1263768A (en) 2000-08-23

Similar Documents

Publication Publication Date Title
CN1785284B (en) Medicinal composition containing flowery knotwood root
CN101279012A (en) Chinese medicine tea for weight reduction, toxin elimination and beauty treatment and matching Chinese medicinal composition
CN105535448A (en) Traditional Chinese medicine composition for treating child myasthenia gravis
CN1104255C (en) Water extracting process for high activity glossy ganoderma holoside and high content glossy ganoderma acid
CN1086299C (en) Chinese-medicinal oral nerve growth liquid
CN101856431B (en) Medicament for treating liver-kidney yin deficiency type anovulatory dysfunctional uterine bleeding, and preparation method and application thereof
CN104474459A (en) Traditional Chinese medicine preparation with liver protection effect and preparation method thereof
CN109876127B (en) Blood-nourishing angelica sinensis capsule and preparation method thereof
CN111956715A (en) Medicine for treating alcoholic liver disease and preparation method thereof
CN1240655A (en) Face-nursing stigma croci tea and its making method
CN111803576A (en) Compound serissa capsule for treating gout
CN112426510B (en) Composition for treating arthritis and preparation method thereof
CN105920450A (en) Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition
CN108434258A (en) A kind of promoting blood circulation bubble foot composition and preparation method thereof
CN102397404B (en) Tea paste for treating limb anesthesia dolorosa and preparation method thereof
CN105770248A (en) Traditional Chinese medicine composition for treating keratitis as well as preparation method and application thereof
CN105902772B (en) Process for purifying effective components of paris polyphylla, pseudo-ginseng and isatis leaf extract
CN105168160A (en) Antelope cold pill and preparation method thereof
CN105535275A (en) Huanglian Shangqing tablet and preparation method thereof
CN115944687A (en) Traditional Chinese medicine formula for improving male idiopathic oligospermia, decoction and tablet
CN113058003A (en) Liqueur and preparation method and application thereof
CN1418656A (en) Capsule for treating gynaecologic inflammation, and its prepn. process
CN114470128A (en) Herbal atomized composition for promoting intelligence and refreshing brain and preparation method thereof
CN113181321A (en) Medicine for treating gynecological uterine fibroid ovarian cyst and preparation method thereof
CN110538267A (en) Traditional Chinese medicine composition with remarkable alopecia prevention effect and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term

Granted publication date: 20020619

CX01 Expiry of patent term